RxDoctor Payments Data

Chasity Downey, PA

Physician Assistant · Conroe, TXNPI 1275954695

Payments from drug & device makers

$2,816in general payments, 2019–2025

Across 135 payments — averaging $20.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$176
  • Medtronic$154
  • Boston Scientific$148
  • Tactile Systems Technology Inc$116
  • Actelion Pharmaceuticals US, Inc.$114
  • plus $692 from 14 others

What the payments were for

  • Food & beverage$2,816100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,816 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$26,865
Medicare patients
236
Services billed
494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban63$80,656
XareltoRivaroxaban53$59,004
EntrestoSacubitril/Valsartan20$35,282
Metoprolol Succinate281$3,792
Valsartan100$3,032
Flecainide Acetate57$2,621
Nifedipine ErNifedipine53$2,087
Atorvastatin Calcium133$2,041
Rosuvastatin Calcium137$1,534
Midodrine Hcl17$1,327
Nebivolol Hcl15$1,182
ClopidogrelClopidogrel Bisulfate59$882
Carvedilol96$849
Potassium Chloride37$710
Amlodipine Besylate100$633

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$56$80,65663 claims
Johnson & JohnsonXarelto$176$59,00453 claims
NovartisEntresto$1,416$35,28220 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Conroe

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →